Opus Genetics is conducting a trial for OPGx-MERTK gene therapy in Abu Dhabi, targeting MERTK-related retinitis pigmentosa ...

The FDA granted orphan drug designation to OpCT-001 for the treatment of retinitis pigmentosa, according to a press release ...

Round led by new investor Life Sciences at Goldman Sachs Alternatives with participation by new investor the Retinal Degeneration Fund, and ...

SparingVision Doses First Patient with SPVN20 for Advanced Retinitis Pigmentosa in NYRVANA Trial SPVN20 aims to restore visual acuity and aspects of color vision by creating an alternative ...

Ocugen Inc ((OCGN)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...

This study received no specific financial support. Informed consent was obtained from all patients included in this study. 1 Lal T, Yu ZX, Guan B, Bender C, Chan CC, Cukras CA, et al. Clinical and ...

Researchers have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa. Researchers at ...

OTTAWA, Oct 10 (Reuters) - The specific deals that Canada is negotiating with the U.S. in key sectors such as steel, aluminum and autos are likely to persist even if the United States-Canada-Mexico ...

Love Is Blind is back in full force for season nine, and one of the singles hoping to find love, Madison Maidenberg, has moved viewers by speaking out about her rare health condition: a recessive form ...

A new approach to gene therapy for retinitis pigmentosa may help patients with advanced disease regain vision regardless of which genetic mutation is causing the condition. An optogenetic therapy ...